MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$147,441K
Net Income
-$2,492K
Net Profit Margin
-1.69%
EPS
-$0.02
Unit: Thousand (K) dollars
Revenue Breakdown
    • Health Care Specialty Pharmacy
    • Fee For Service
    • Capitated Revenue
    • Clinical Research Trials And Oth...
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total operating revenue
147,441
141,957
136,564
119,802
Direct costs-Health Care Patient Service
53,383
52,700
54,572
51,150
Direct costs-Dispensary Revenue
-
-
63,072
51,086
Direct costs-Health Care Specialty Pharmacy
70,743
66,537
-
-
Direct costs-Clinical Research Trials And Other Revenue
0
-45
0
65
Selling, general and administrative expense
28,212
28,040
25,251
26,907
Depreciation and amortization
1,616
1,632
1,723
1,805
Total operating expenses
153,954
148,864
144,618
131,013
Loss from operations
-6,513
-6,907
-8,054
-11,211
Interest expense, net
1,934
1,916
1,920
1,870
Change in fair value of derivative warrant liabilities
-168
1
150
53
Change in fair value of conversion option derivative liabilities
4,996
1,067
-5,977
-3,987
Other, net
791
249
-403
-19
Total other non-operating expense (income)
4,021
-601
-8,450
-5,929
Loss before provision for income taxes
-2,492
-7,508
-16,504
-17,140
Income taxes
0
0
0
-131
Net loss
-2,492
-7,508
-16,504
-17,009
Basic EPS
-0.02
-0.074
-0.14
-0.15
Diluted EPS
-0.02
-0.074
-0.14
-0.15
Basic Average Shares
101,801,609
101,780,237
97,474,797
93,203,665
Diluted Average Shares
101,801,609
101,780,237
97,474,797
93,203,665
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$2,492K (87.28%↑ Y/Y)Change in fair value ofconversion option...$4,996K (250.98%↑ Y/Y)Fee For Service$32,156K (-9.61%↓ Y/Y)Capitated Revenue$26,931K (53.94%↑ Y/Y)Other, net$791K (205.19%↑ Y/Y)Change in fair value ofderivative warrant...-$168K (-490.70%↓ Y/Y)Loss beforeprovision for income taxes-$2,492K (87.28%↑ Y/Y)Total othernon-operating expense...$4,021K (141.57%↑ Y/Y)Health Care SpecialtyPharmacy$87,541K Health Care PatientService$59,087K (11.34%↑ Y/Y)Clinical Research TrialsAnd Other Revenue$813K (-60.24%↓ Y/Y)Interest expense, net$1,934K (-65.28%↓ Y/Y)Loss from operations-$6,513K (34.29%↑ Y/Y)Total operatingrevenue$147,441K (41.22%↑ Y/Y)Total operatingexpenses$153,954K (34.67%↑ Y/Y)Direct costs-HealthCare Specialty...$70,743K Direct costs-HealthCare Patient Service$53,383K (13.39%↑ Y/Y)Selling, general andadministrative expense$28,212K (11.18%↑ Y/Y)Depreciation andamortization$1,616K (-9.42%↓ Y/Y)

Oncology Institute, Inc. (DFPH)

Oncology Institute, Inc. (DFPH)